A Nomogram for Predicting Survival in Advanced Non-Small-Cell Lung Carcinoma Patients: A Population-Based Study

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590.
   PubMed Web of Science ®Google Scholar
• Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24. doi:10.1016/j.ccm.2019.10.001.
   PubMed Web of Science ®Google Scholar
• Cardoso D, Painho M, Roquette R. A geographically weighted regression approach to investigate air pollution effect on lung cancer: a case study in Portugal. Geospatial Health. 2019; 14:35–45. doi:10.4081/gh.2019.701.
   Web of Science ®Google Scholar
• Warren GW, Ward KD. Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. Transl Lung Cancer Res. 2015;4(4):339–352. doi:10.3978/j.issn.2218-6751.2015.07.15.
   PubMedGoogle Scholar
• Barrington-Trimis JL, Braymiller JL, Unger JB, McConnell R, Stokes A, Leventhal AM, et al. Trends in the age of cigarette smoking initiation among young adults in the US From 2002 to 2018. JAMA Netw Open. 2020;3(10):e2019022. doi:10.1001/jamanetworkopen.2020.19022.
   PubMed Web of Science ®Google Scholar
• Schwartz AG, Cote ML. Epidemiology of lung cancer. Adv Exp Med Biol. 2016; 893:21–41. doi:10.1007/978-3-319-24223-1_2.
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin J, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–1260. doi:10.1097/JTO.0000000000000630.
   PubMed Web of Science ®Google Scholar
• Chen S, Gao C, Du Q, Tang L, You H, Dong Y. A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study. J Transl Med. 2020;18(1):436. doi:10.1186/s12967-020-02606-3.
   PubMed Web of Science ®Google Scholar
• Piperdi B, Merla A, Perez-Soler R. Targeting angiogenesis in squamous non-small cell lung cancer. Drugs. 2014;74(4):403–413. doi:10.1007/s40265-014-0182-z.
   PubMed Web of Science ®Google Scholar
• Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117. doi:10.1038/s41419-017-0063-y.
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234(3):360–369. doi:10.1097/00000658-200109000-00010.
   PubMed Web of Science ®Google Scholar
• Zheng XQ, Huang JF, Lin JL, Chen L, Zhou TT, Chen D, et al. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. Transl Lung Cancer Res. 2019;8(4):367–379. doi:10.21037/tlcr.2019.08.16.
   PubMed Web of Science ®Google Scholar
• Osmani L, Askin F, Gabrielson E, Li QK. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2018;52(Pt 1):103–109. doi:10.1016/j.semcancer.2017.11.019.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang L, Ci B, Maclean M, Gerber DE, Xiao G, Xie Y. Development and validation of a nomogram prognostic model for SCLC patients. J Thorac Oncol. 2018;13(9):1338–1348. doi:10.1016/j.jtho.2018.05.037.
   PubMed Web of Science ®Google Scholar
• Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861–869. doi:10.1200/JCO.2014.56.6661.
   PubMed Web of Science ®Google Scholar
• Duan H, Liang L, Xie S, Wang C. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study. BMC Cancer. 2020;20(1):809. doi:10.1186/s12885-020-07309-y.
   PubMed Web of Science ®Google Scholar
• Song Q, Shang J, Zhang C, Zhang L, Wu X. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients. J Cancer Res Clin Oncol. 2019;145(3):737–746. doi:10.1007/s00432-018-02826-7.
   PubMed Web of Science ®Google Scholar
• Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011;29(23):3163–3172. doi:10.1200/JCO.2010.33.1595.
   PubMed Web of Science ®Google Scholar
• Muschelli J. ROC and AUC with a binary predictor: a potentially misleading metric. J Classif. 2020;37(3):696–708. doi:10.1007/s00357-019-09345-1.
   PubMed Web of Science ®Google Scholar
• Thomas LE, O'Brien EC, Piccini JP, D’Agostino RB, Pencina MJ. Application of net reclassification index to non-nested and point-based risk prediction models: a review. Eur Heart J. 2019;40(23):1880–1887. doi:10.1093/eurheartj/ehy345.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D'Agostino RB, Sr, D’Agostino RB, Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–212. doi:10.1002/sim.2929.
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X06295361.
   PubMed Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek J, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi:10.1016/j.eururo.2018.08.038.
   PubMed Web of Science ®Google Scholar
• Schork NJ. Artificial intelligence and personalized medicine. Cancer Treat Res. 2019; 178:265–283. doi:10.1007/978-3-030-16391-4_11.
   PubMedGoogle Scholar
• Koul R, Rathod S, Dubey A, Bashir B, Chowdhury A. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment. Lung Cancer. 2018;123:116–120. doi:10.1016/j.lungcan.2018.06.029.
   PubMed Web of Science ®Google Scholar
• Wang BY, Huang JY, Cheng CY, Lin CH, Ko J, Liaw YP. Lung cancer and prognosis in Taiwan: a population-based cancer registry. J Thorac Oncol. 2013;8(9):1128–1135. doi:10.1097/JTO.0b013e31829ceba4.
   PubMed Web of Science ®Google Scholar
• Zeng B, Ji P, Chen C, Sun J, Gu C, Shang A, et al. A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer. Int J Biochem Cell Biol. 2020; 127:105825. doi:10.1016/j.biocel.2020.105825.
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang X, Zhong P, Yin G, Fan X, Huang C. A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study. Oncol Lett. 2019;18(6):5905–5916. doi:10.3892/ol.2019.10977.
   PubMed Web of Science ®Google Scholar
• Deng J, Ren Z, Wen J, Wang B, Hou X, Xue Z, et al. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer. Cancer Manag Res. 2018; 10:6143–6156. doi:10.2147/CMAR.S183878.
   PubMed Web of Science ®Google Scholar
• Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P. Lung cancer: biology and treatment options. Biochim Biophys Acta. 2015;1856(2):189–210. doi:10.1016/j.bbcan.2015.08.002.
   PubMed Web of Science ®Google Scholar
• Yang J, Peng A, Wang B, Gusdon AM, Sun X, Jiang G, et al. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis. Clin Exp Metastasis. 2019;36(5):457–466. doi:10.1007/s10585-019-09985-y.
   PubMed Web of Science ®Google Scholar
• Yin G, Xiao H, Liao Y, Huang C, Fan X. Construction of a nomogram after using propensity score matching to reveal the prognostic benefit of tumor resection of stage IV M1a nonsmall cell lung cancer patients. Cancer Invest. 2020;38(5):277–288. doi:10.1080/07357907.2020.1753761.
   PubMed Web of Science ®Google Scholar
• Liao Y, Yin G, Fan X. The positive lymph node ratio predicts survival in T1-4N1-3M0 non-small cell lung cancer: a nomogram using the SEER database. Front Oncol. 2020;10:1356. doi:10.3389/fonc.2020.01356.
   PubMed Web of Science ®Google Scholar
• Wong ML, Clarke CA, Yang J, Hwang J, Hiatt RA, Wang S. Incidence of non-small-cell lung cancer among California Hispanics according to neighborhood socioeconomic status. J Thorac Oncol. 2013;8(3):287–294. doi:10.1097/JTO.0b013e31827bd7f5.
   PubMed Web of Science ®Google Scholar
• Song P, Wu X, Yang L, Ma K, Liu Z, Zhou J, et al. Second malignant tumors and non-tumor causes of death for patients with penile cancer during their survivorship. Cancer Control. 2022;29:10732748221134789. doi:10.1177/10732748221134789.
   Web of Science ®Google Scholar